Introduction {#sec1-1}
============

^18^F-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) imaging in combination with computed tomography (CT) is mainly used to assess malignant lesions.\[[@ref1]\]

However, in normal tissue ^18^F-FDG also accumulates in various degrees.\[[@ref2]\] It is essential to know what this physiological uptake is, in order to discriminate between normal and pathological findings. Moreover, testicular ^18^F-FDG uptake correlates positively with the main sperm parameters and is likely to be a promising parameter for testis function.\[[@ref3]\]

In testicular tissue, normal ^18^F-FDG uptake has been studied in men over the age of 35 and in a pediatric study population.\[[@ref4][@ref5][@ref6]\] However, data on men between the ages of 18 and 32 years and on the reliability of the ^18^F-FDG uptake measurements are lacking.

Therefore, the aim of this study is to measure the physiological testicular ^18^F-FDG uptake in young men and to assess the usability of these measurements by calculating the laterality indices and the inter- and intra-observer variation.

Materials and Methods {#sec1-2}
=====================

Study population {#sec2-1}
----------------

During the period of January 2012 to April 2013, a total of 1555 men underwent a diagnostic whole body FDG-PET/CT scan in our hospital. In the age group of our interest (18-32 years), 20 scans (40 testes) were performed on men with a mean age of 26.5 ± 3.9 years (range: 19.3-31.2 years). All PET/CT scans were carried out with the same type of scanner. Indications for the diagnostic whole body FDG-PET/CT scans included Hodgkin\'s disease (8), suspicion of malignancy (4), colon carcinoma (3), sarcoidosis (2), tuberculosis (1), B-cell lymphoma (1), and a suspicion of endocarditis (1). None of the patients had a history of undescended testis or showed any abnormality of the testes on the PET/CT scan.

Each patient gave written informed consent for the evaluation of their PET/CT data for scientific research.

^18^F-fluoro-2-deoxyglucose positron emission tomography/computed tomography scan {#sec2-2}
---------------------------------------------------------------------------------

Whole-body ^18^F-FDG PET/CT scanning was performed using a Biograph 16 TruePoint PET/CT scanner (Siemens Healthcare, Knoxville, USA).

All 20 patients had a blood glucose level below 10 mmol/l and received an intravenous injection of FDG. The average injected dose was 4.7 MBq/kg body weight (range: 2.4-6.4 MBq/kg), and the average time between FDG administration and the start of the PET acquisition was 62 min (range: 44-74 min).

In 10 patients, a low-dose CT scan was performed for localization and attenuation correction purposes. Scanning parameters included 50 reference mAs and 130 kV with 4D Care Dose (Siemens Healthcare, Knoxville, USA). No intravenous contrast was administered to these patients. A diagnostic CT total body with 110 reference mAs and 110 or 130 kV with 4D Care Dose was acquired for the other 10 patients, and these patients were given intravenous contrast.

For PET scanning, a three-dimensional emission scan was acquired with 6 or 7 bed position (195 and 225 transaxial images, respectively), using 4 min/bed position. Images with CT-based attenuation correction were reconstructed, using ordered subset expectation maximization three-dimensional reconstruction with fourth iterations, eight subsets, a Gaussian postsmoothing filter of 5 mm, 168 × 168 matrix, pixel size 4.07 mm × 4.07 mm, and slice thickness 5 mm.

Image analysis and parameters {#sec2-3}
-----------------------------

Images \[[Figure 1](#F1){ref-type="fig"}\] were interpreted on syngo. via VA20A equipped workstations, using the MM Oncology software package (version 1.0; Siemens Healthcare, Erlangen, Germany), which can display CT, PET, and fused PET/CT images simultaneously.

![Example of positron emission tomography/computed tomography images in a patient with symmetric testicular uptake of fluoro-2-deoxyglucose, coronal (a) and axial (b)](WJNM-13-88-g001){#F1}

In order to measure testicular volume by CT, the testes were selected semi-automatically using the generic segmentation tool in this software package. The resulting selected area was checked visually in all orthogonal planes (slice thickness 2 mm) and reshaped manually in case of obvious errors. Subsequently, the testicular volumes were calculated automatically by summing the volume estimates from the selected areas in each slice.

Standardized uptake values were calculated from the PET images as the ratio of the activity (kBq) in tissue per milliliter to the activity in the injected dose (MBq) per patient body weight in kilogram. Volume of interests (VOIs) were selected on the PET images using the VOI isocontour tool in the oncology software package mentioned above, with a threshold of 50%. Spheres were placed manually around each testis on the three-dimensional PET images and rotated to the correct orientation of the testis. Within the resulting isocontour, SUV~max~ (SUV of a single pixel with highest uptake in the VOI), SUV~peak~ (mean SUV of 1 cm^3^ with highest uptake in VOI), SUV~mean~ (mean SUV in whole VOI) and the volume of the VOI were measured and recorded.

All scans were assessed by three researchers (observer 1, 2, and 3), one of them assessed every scan twice (observer 3^a^ and 3^b^).

Statistical analysis {#sec2-4}
--------------------

All data were managed and analyzed with SPSS, version 14.0 (SPSS Inc, Chicago, Ill). The laterality index was defined as (ǀ*L*- *R*ǀ/(*L* + *R*) ×2), where *L* = left testicular SUV and *R* = right testicular SUV.\[[@ref5]\] The intraclass correlation coefficient (ICC) was used to evaluate inter- and intra-observer variability; the ICC is 1.0 if there is a perfect reliability. Furthermore, linear regression was used to calculate the exact correlation between the three different researchers (interobserver variation) and between the first and second assessment of one of the researchers (intraobserver variation).\[[@ref7][@ref8]\] A correlation coefficient (r) \>0.7 was regarded as a good correlation. Linear regression was expressed as *Y* = a + bx, where the intercept (a) is 0 and the slope (b) is 1 if there is a perfect correlation. The correlations between the SUV~max~ and SUV~peak~, between SUV~mean~ and SUV~peak~ and between age and SUV~peak~ were assessed with linear regression and the Pearson\'s correlation coefficient test. *P* \<0.05 was considered as statistically significant.

Results {#sec1-3}
=======

[Table 1](#T1){ref-type="table"} shows the mean and laterality indices of the SUV~max~, SUV~peak~, and SUV~mean~, testicular volume on CT and VOI of the 40 healthy testes in young men.

###### 

Mean±SD and range of SUV~max~, SUV~peak~, SUV~mean~, TV on CT and VOI and their laterality indices measured by three researchers on 20 ^18^FDGPET/CT scans of young men with 40 healthy testes

![](WJNM-13-88-g002)

Inter- and intra-observer reliability {#sec2-5}
-------------------------------------

The interobserver ICCs (+95% confidence interval \[CI\]) of the SUV~max~, SUV~peak~, and SUV~mean~, testicular volume on CT, and VOI are shown in [Table 2](#T2){ref-type="table"}. The interobserver ICC for the testicular volumes on CT with contrast (*n* = 10) was 0.890 (0.768-0.953) and for the CT scans without contrast (*n* = 10) 0.805 (0.589-0.917).

###### 

Interobserver and intraobserver variability of SUV~max~, SUV~peak~, SUV~mean~, TV on CT and VOI measured on 20 ^18^FDG-PET/CT scans of young men with 40 normal testes, expressed as ICC

![](WJNM-13-88-g003)

Also shown in [Table 2](#T2){ref-type="table"} are the intraobserver ICCs (+95% CI) of the SUV~max~, SUV~peak~, and SUV~mean~, testicular volume on CT, and VOI. The intraobserver ICC for the testicular volumes on CT with contrast (*n* = 10) was 0.893 (0.729-0.958) and for the CT scans without contrast (*n* = 10) 0.934 (0.832-0.974).

The exact inter- and intra-observer correlation as measured by linear regression for all parameters is presented in [Table 3](#T3a){ref-type="table"}.

###### 

Interobserver (A) and intraobserver (B) variability of SUV~max~, SUV~peak~, SUV~mean~, TV on CT and VOI measured on 20 ^18^FDG-PET/CT scans of young men with 40 normal testes, calculated by linear regression and expressed as correlation coefficient (*r*), intercept (*a*) and slope (*b*)

![](WJNM-13-88-g004)

###### 

Interobserver (A) and intraobserver (B) variability of SUV~max~, SUV~peak~, SUV~mean~, TV on CT and VOI measured on 20 ^18^FDG-PET/CT scans of young men with 40 normal testes, calculated by linear regression and expressed as correlation coefficient (*r*), intercept (*a*) and slope (*b*)

![](WJNM-13-88-g005)

Correlation between standardized uptake value (SUV~max~) and SUV~peak~ {#sec2-6}
----------------------------------------------------------------------

There was a significant, strong positive correlation between the SUV~max~ and SUV~peak~; r = 0.973; *Y* = 0.07 + 0.97*x*, *P* \< 0.0001 \[[Figure 2](#F2){ref-type="fig"}\].

![Strong positive correlation between the standardized uptake value (SUV)~max~ and SUV~peak~ of the ^18^Fluoro-2-deoxyglucose-positron emission tomography/computed tomography imaging of young men with 40 normal testes and four measurements. *r* = 0.973; *Y* = 0.07 + 0.97*x*; *P* \< 0.0001](WJNM-13-88-g006){#F2}

Correlation between standardized uptake value (SUV~mean~) and SUV~peak~ {#sec2-7}
-----------------------------------------------------------------------

There was a significant, strong positive correlation between the SUV~mean~ and SUV~peak~; r = 0.984; *Y* = 0.1 + 0.98x, *P* \< 0.0001 \[[Figure 3](#F3){ref-type="fig"}\].

![Strong positive correlation between the standardized uptake value (SUV)~mean~ and SUV~peak~ of the ^18^Fluoro-2-deoxyglucose-positron emission tomography/computed tomography imaging of young men with 40 normal testes and four measurements. *r* = 0.984; *Y* = 0.1 + 0.98x; *P* \< 0.0001](WJNM-13-88-g007){#F3}

Correlation between age and standardized uptake value~peak~ {#sec2-8}
-----------------------------------------------------------

There was a significant, weak positive correlation between age and the SUV~peak~. *r* = 0.349; *Y* = 1.7 + 0.35x, *P* \< 0.0001 \[[Figure 4](#F4){ref-type="fig"}\].

![Weak positive correlation between the age and standardized uptake value~peak~ of the ^18^Fluoro-2-deoxyglucose-positron emission tomography/computed tomography imaging of young men with 40 normal testes and four measurements. *r* = 0.349; *Y* = 1.75 + 0.35x; *P* \< 0.0001](WJNM-13-88-g008){#F4}

Discussion {#sec1-4}
==========

In this study, on testicular ^18^F-FDG uptake on PET/CT in a population of young men, we found a high inter- and intra-observer reliability in assessing the SUV~max~, as well as the SUV~peak~ and the SUV~mean~. Further, these SUVvalues had low laterality indices and correlated well with each other. Furthermore, the correlation between the SUV~peak~ and age was weak.

In their study, Kosuda *et al*. they found a testicular SUV ranging from 1.90 to 3.34 (average; 2.44 ± 0.53), Kitajima *et al*. have reported a mean SUV~max~ of 2.81 ± 0.43 in the age group of 30-39, and the highest mean SUV~mean~ Goethals *et al*. found in a pediatric population was 1.4.\[[@ref4][@ref5][@ref6]\] Absolute uptake values such as SUVs are known to be affected by many technical and physiological factors. Therefore, measurements from different studies cannot reliably be compared.\[[@ref9][@ref10][@ref11]\] Nevertheless, the positive correlation (*r* = 0.406, *P* = 0.005) between age and the SUV~mean~ described by Goethals *et al*. have been interpreted as not in line with the negative correlation (*r* = −0.284, *P* \< 0.0001) between age and SUV~max~ that Kitajima *et al*. described from the age of 36. In our study, we interpreted the positive correlation between age and SUV~peak~ (*r* = 0.349; *Y* = 1.7 + 0.35x; *P* \< 0.0001) as significant, but weak.

Although Goethals *et al*. interpreted their results as not in line with the results of Kitajima *et al*., the reverse correlation may be a consequence of the maturation of testes in child- and adulthood and on the other hand, the aging of the testes with deterioration of the Leydig cells during the second part of a man\'s life.\[[@ref12][@ref13]\] Our finding of a significant, but weak correlation between age (19.3-32.2 years) and SUV~peak~ supports this theory since in our age group testicles are mature, but do not alter yet.

Furthermore, in this study, we found that the laterality of testicular ^18^F-FDG uptake is low: the laterality indices for SUV~max~, SUV~peak~, and SUV~mean~ were 0.077 ± 0.065, 0.074 ± 0.066, and 0.072 ± 0.063, respectively. These findings are comparable with the laterality indices of the SUV~max~ reported by Kitajima *et al*. (0.066 ± 0.067).\[[@ref5]\] This implies that the SUVs are comparable for bilateral testes; there is high symmetry in healthy testes and that a higher laterality index (for instance \> 0.15) may be an indication for a pathologic process.

In addition, inter- and intra-observer variability were evaluated. There was a weak inter- and intra-observer reliability in the testicular volumes measured on CT (with or without contrast) as well as in the VOI on the PET/CT. Moreover, the correlation between both parameters was moderate (*r* = 0.513; *Y* = 11.5 + 0.5x; *P* \< 0.0001). This leads to the conclusion that testicular volume is an unreliable parameter to evaluate using a PET/CT scan. However, all standard uptake values (max, peak and mean) showed a very good inter- and intra-observer repeatability. SUV~max~ corresponds with the single pixel with the highest ^18^F-FDG uptake in the VOI and is of particular value in PET/CT images of high statistical quality.\[[@ref14]\] SUV~peak~, which represents the mean SUV of the 1 cm^3^ with the highest ^18^F-FDG uptake in the VOI, provides a slightly more robust alternative. The ICCs of inter- and intra-observer variability are 1.0 and 0.999, respectively; therefore, the SUV~peak~ seems a perfectly reliable parameter. This parameter has an average ± standard deviation of 3.06 ± 0.54, a laterality index of 0.074 ± 0.066 and good correlations with SUV~max~ (*r* = 0.973; *Y* = 0.07 + 0.97x; *P* \< 0.0001) and SUV~mean~ (*r* = 0.984; *Y* = 0.1 + 0.98x; *P* \< 0.0001); as a result, the SUV~peak~ appears to be an ideal parameter for the evaluation of testicular ^18^F-FDG uptake.

The limitations of this study need to be addressed. First, number of scans (20) and testes (40) is relatively small. Since January 2012 a new scanner has been in use and as the scanner might influence the SUVs, it was decided to include only the PET/CT scans made on this new scanner. Besides, scans were included only of men in the age group of our interest (18-32 years). These two inclusion criteria limited number of scans to 20, with 40 testes.

Second, this was a retrospective study. Testes were not placed in a proper position and in some cases both testes were in contact with each other which hampered the automatic detection of the testis with the generic segmentation tool on CT. Further, although the scans were performed on the same scanner, there were some differences in the scanning protocol. For example, intravenous contrast agent was used in half the scans, whereas in the other half no contrast agent was administered. Analysis showed a significantly higher SUV~max~ in the group with contrast agent compared with the group without contrast agent (3.57 ± 0.6 vs. 3.27 ± 0.58; *P* = 0.034), but no significant differences were found between both groups for the SUV~peak~ (3.17 ± 0.55 vs. 2.95 ± 0.51; *P* = 0.1) and SUV~mean~ (2.53 ± 0.44 vs. 2.34 ± 0.42; *P* = 0.07). The retrospective character of this study may have caused some inaccuracy in the results and can be improved in a future prospective study with a proper positioning of both testes and one single scanning protocol.

Third, our study population contained a group of men with a variety of diseases with corresponding (chemo) therapies. Because an excess of FDG is given before scanning, cancerous or otherwise pathologic tissue does not compromise the FDG uptake of normal tissue, that is, testicles. The influence of chemotherapy on testicular FDG uptake has been studied by Burger *et al*.\[[@ref15]\] They found no absolute or relative change in testicular FDG uptake after starting or during systemic chemotherapy for Hodgkin\'s lymphoma. Furthermore, no involvement of the testes in the pathology of our study population had been diagnosed. Furthermore, no other testicular abnormalities were seen on the PET/CT scans. Overall, we believe that there was no influence of diseases with the corresponding therapies in our study population on the measured SUV values.

In short, SUV measurements with PET/CT of testicular ^18^F-FDG uptake seem reliable with a low inter- and intra-observer variability and high symmetry in young men with normal testes. SUV~peak~ seems to be the best parameter to use in the evaluation of this uptake. Consequently, the PET/CT seems a promising new method to evaluate testicular function, and this conclusion is supported by recently published data on the positive correlation between the rate of testicular ^18^F-FDG uptake and sperm parameters.\[[@ref3]\] The PET/CT scan will enable us to discriminate between the functioning of both bilateral testes. Therefore, it will overcome an important limitation of the main fertility parameters used previously, such as semen analysis or paternity.\[[@ref16]\] For example, the testicular ^18^F-FDG uptake measured on PET/CT might become an important parameter in the evaluation of the functioning of previously unilateral orchidopexied testes.

Conclusion {#sec1-5}
==========

Testicular ^18^F-FDG uptake in young men can be measured accurately using PET/CT, with a low inter- and intra-observer variability and shows high symmetry. ^18^F-FDG PET/CT has the potential to become a useful instrument in the evaluation of the functioning of the individual testis.
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